/press-release/wuxi-biologics-mfg8-drug-substance-facility-secures-fda-pli-approval-advancing-commercial-supply-of-a-potential-blockbuster-autoimmune-therapy/ 提供端到端一站式解决方案 Thu, 09 Jul 2026 01:57:13 +0000 hourly 1